Bailard’s Dermira, Inc. DERM Stock Holding History

Bailard’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-108,000	Closed	-$22K	–	581
2018 Q2	$22K	Buy	+108,000	New	+$1.01M	﹤0.01%	509

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bailard's DERM Position: Q1 2019 in Review

Bailard sold out of Dermira, Inc. (DERM) in Q1 2019, closing a stake of 143,000 shares — an estimated $1.03M sold.

Bailard first reported a position in DERM in Q1 2018 and held it in 4 quarters. The position peaked at $1.56M in Q3 2018. 144 funds tracked by Wall St. Rank hold DERM as of Q1 2019.

Bailard reported no remaining Dermira, Inc. position as of Q1 2019 after selling out during the quarter.
Bailard sold 143,000 Dermira, Inc. shares in Q1 2019, an estimated $1.03M.
Bailard first reported a position in Dermira, Inc. in Q1 2018 and held it in 4 quarters.
Bailard's Dermira, Inc. position peaked at $1.56M in Q3 2018.
144 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2019.

Based on Bailard's 13F filing for Q1 2019, filed 24 Apr 2019.